% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

fastestgrowingstocks 2 posts  |  Last Activity: Feb 8, 2012 7:31 PM Member since: Feb 8, 2012

    Wednesday, February 01, 2012

    .: Followup to REPCF cure for baldness. Interview with CEO :.

    NBT Two-Minute Drill Interview with David Hall, CEO of Replicel Life Sciences

    We recently interviewed David Hall, CEO of Replicel Life Sciences, Inc., on the upcoming Phase I/IIa clinical trial results “reveal” for their cell-based hair regeneration technology some 90 or so days away.

    With positive results expected from their current Phase I/IIa trial, Replicel will move immediately into a 100-patient dosing trial from which it hopes to build an overwhelming set of successful data for the patented RepliCel™ procedure for minimally invasive hair cell growth and implantation.

    With two successful data-sets in hand, Replicel intends to sell its entire hair growth and implantation business to the highest Big Pharma/Big Bio bidder. NBT analyses the value of their follicular regeneration business at about $500 million—or more than $10 a share with an expected 10 million share dilution from money raising activities in 2012.


  • fastestgrowingstocks by fastestgrowingstocks Feb 8, 2012 7:23 PM Flag

    at this website that specializes in fast growing stocks under 5.

    discusses ramping demand for graphite, especially in China

235.94+3.58(+1.54%)May 27 4:00 PMEDT